Equities analysts predict that National Health Investors, Inc. (NYSE:NHI) will announce $1.34 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for National Health Investors’ earnings, with estimates ranging from $1.32 to $1.36. National Health Investors posted earnings of $1.25 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 7.2%. The company is scheduled to announce its next earnings results before the market opens on Tuesday, May 8th.
According to Zacks, analysts expect that National Health Investors will report full-year earnings of $5.50 per share for the current fiscal year, with EPS estimates ranging from $5.48 to $5.52. For the next year, analysts expect that the business will post earnings of $5.65 per share, with EPS estimates ranging from $5.62 to $5.70. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow National Health Investors.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Friday, February 16th. The real estate investment trust reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.33 by ($0.43). The firm had revenue of $71.06 million for the quarter, compared to analysts’ expectations of $71.36 million. National Health Investors had a net margin of 57.19% and a return on equity of 12.20%.
Several equities analysts recently issued reports on NHI shares. Stephens set a $79.00 price objective on shares of National Health Investors and gave the company a “buy” rating in a research note on Friday, January 12th. Hilliard Lyons raised shares of National Health Investors from a “neutral” rating to a “buy” rating in a research note on Friday, February 16th. Stifel Nicolaus set a $76.00 price objective on shares of National Health Investors and gave the company a “buy” rating in a research note on Saturday, February 17th. BMO Capital Markets set a $70.00 price objective on shares of National Health Investors and gave the company a “hold” rating in a research note on Monday, March 26th. Finally, Mizuho reaffirmed a “hold” rating and set a $70.00 price target on shares of National Health Investors in a research report on Monday, February 26th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $74.67.
In other National Health Investors news, VP John L. Spaid acquired 500 shares of the company’s stock in a transaction dated Thursday, February 22nd. The stock was bought at an average price of $64.95 per share, with a total value of $32,475.00. Following the completion of the transaction, the vice president now directly owns 971 shares of the company’s stock, valued at $63,066.45. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn acquired 2,000 shares of the company’s stock in a transaction dated Thursday, February 22nd. The stock was acquired at an average cost of $65.47 per share, with a total value of $130,940.00. Following the transaction, the chief executive officer now directly owns 10,580 shares of the company’s stock, valued at $692,672.60. The disclosure for this purchase can be found here. Insiders have purchased 2,812 shares of company stock valued at $183,910 in the last ninety days. 5.19% of the stock is currently owned by company insiders.
Several institutional investors have recently added to or reduced their stakes in NHI. Zeke Capital Advisors LLC acquired a new stake in shares of National Health Investors in the fourth quarter worth $226,000. Cubist Systematic Strategies LLC acquired a new stake in shares of National Health Investors in the third quarter worth $237,000. Stephens Inc. AR acquired a new stake in shares of National Health Investors in the fourth quarter worth $238,000. Xact Kapitalforvaltning AB acquired a new stake in shares of National Health Investors in the fourth quarter worth $283,000. Finally, Vident Investment Advisory LLC acquired a new stake in shares of National Health Investors in the fourth quarter worth $323,000. 71.84% of the stock is owned by institutional investors.
Shares of NHI traded down $1.01 on Friday, hitting $65.57. 144,239 shares of the stock traded hands, compared to its average volume of 263,024. The company has a debt-to-equity ratio of 0.87, a quick ratio of 13.85 and a current ratio of 13.85. The company has a market capitalization of $2,808.40, a price-to-earnings ratio of 12.49, a PEG ratio of 3.51 and a beta of 0.43. National Health Investors has a 1 year low of $62.71 and a 1 year high of $81.60.
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, March 30th will be given a dividend of $1.00 per share. This is a positive change from National Health Investors’s previous quarterly dividend of $0.95. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $4.00 annualized dividend and a yield of 6.10%. National Health Investors’s dividend payout ratio is 75.05%.
ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Expect National Health Investors, Inc. (NHI) Will Announce Earnings of $1.34 Per Share” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/20/zacks-analysts-expect-national-health-investors-inc-nhi-will-announce-earnings-of-1-34-per-share.html.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Get a free copy of the Zacks research report on National Health Investors (NHI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.